Drug Therapy < Drug Therapy, Combination < Drug Tolerance

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 230.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000007 (1999)	A. Churchyard [Royaume-Uni] ; C J Mathias ; A J Lees	Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal.
000045 (1999)	R B Innis [États-Unis] ; K L Marek ; K. Sheff ; S. Zoghbi ; J. Castronuovo ; A. Feigin ; J P Seibyl	Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.
000063 (1999)	L E Davis [États-Unis] ; J C Adair	Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
000113 (1999)	W J Weiner [États-Unis]	The initial treatment of Parkinson's disease should begin with levodopa.
000114 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
000153 (1999)	J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L Burnett	The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000164 (1999)	G. Ebersbach [Autriche] ; M. Stöck ; J. Müller ; G. Wenning ; J. Wissel ; Werner Poewe [Autriche]	Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration.
000166 (1999)	T. Mezaki [Japon] ; R. Kaji ; M F Brin ; M. Hirota-Katayama ; T. Kubori ; T. Shimizu ; J. Kimura	Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
000248 (2000)	S A Factor	The initial treatment of Parkinson's disease.
000249 (2000)	J L Montastruc	Treatment of Parkinson's disease should begin with a dopamine agonist.
000271 (2000)	C G Goetz [États-Unis] ; G T Stebbins ; L M Blasucci	Differential progression of motor impairment in levodopa-treated Parkinson's disease.
000274 (2000)	M D Welsh [États-Unis] ; E. Dorflinger ; D. Chernik ; C. Waters	Illness impact and adjustment to Parkinson's disease: before and after treatment with tolcapone.
000280 (2000)	P E Greene [États-Unis] ; S B Bressman ; B. Ford ; K. Hyland	Parkinsonism, dystonia, and hemiatrophy.
000297 (2000)	J. Kulisevsky [Espagne] ; C. García-Sánchez ; M L Berthier ; M. Barbanoj ; B. Pascual-Sedano ; A. Gironell ; A. Estévez-González	Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
000327 (2000)	Werner Poewe [Autriche] ; G K Wenning	Apomorphine: an underutilized therapy for Parkinson's disease.
000356 (2000)	S. Tesei [Italie] ; A. Antonini ; M. Canesi ; A. Zecchinelli ; C B Mariani ; G. Pezzoli	Tolerability of paroxetine in Parkinson's disease: a prospective study.
000364 (2000)	H A Hana Asi [Turquie] ; G. Kaptanoglu ; H A Sahin ; M. Emre	The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa.
000390 (2000)	K J Black [États-Unis] ; J W Mink	Response to levodopa challenge in Tourette syndrome.
000397 (2000)	E. Mohr [Canada] ; T. Mendis ; K. Hildebrand ; P P De Deyn	Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
000407 (2000)	R A Hauser [États-Unis] ; M N Wahba ; T A Zesiewicz ; W. Mcdowell Anderson	Modafinil treatment of pramipexole-associated somnolence.
000411 (2000)	D. Dressler [Allemagne] ; U. Zettl ; R. Benecke ; H. Bigalke	Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Drug Therapy, Combination" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Therapy, Combination
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024